Abstract
The ability to modulate the sensitivity of mammalian cells to ionizing radiation (IR) (e.g. using chemotherapeutics) is dependent on our understanding of the primary target and biochemical pathway that leads to IR-induced apoptosis. We demonstrate using a cell free assay that irradiation of mitochondria is a primary event that initiates IR-induced apoptosis. IR results in loss of mitochondrial membrane potential, opening of the permeability transition pore (PTP) and the release of cytochrome c (cyto c). Apaf-1 and ATP were required to initiate apoptosis upon release of cyto c from mitochondria. The importance of mitochondrial events in the initiation of IR-induced apoptosis was also supported by the observation that inhibition of caspase-9 by the over-expression of dominant negative mutants resulted in the inhibition of IR-induced apoptosis. In contrast, inhibition of caspase-8 had only a minor impact on IR-induced apoptosis. Over-expression of Bcl-XL inhibited the initiation of IR-induced apoptosis due to its ability to prevent the loss of mitochondrial membrane potential, PTP opening and cytochrome c release. In a cell free assay for apoptosis, mitochondria as well as cytosol derived from Bcl-XL over-expressing cells were less efficient at supporting apoptosis in response to IR suggesting multiple roles for Bcl-XL in the regulation of apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ashkenazi A and Dixit VM. . 1998 Science 281: 1305–1308.
Belka C, Marini P, Budach W, Schulze-Osthoff K, Lang F, Gulbins E and Bamberg M. . 1998 Radiat. Res. 149: 588–595.
Booker JK, Reap EA and Cohen PL. . 1998 J. Immunol. 161: 4536–4544.
Cai J and Jones DP. . 1998 J. Biol. Chem. 273: 11401–11404.
Datta R, Kojima H, Banach D, Bump NJ, Talanian RV, Alnemri ES, Weichselbaum RR, Wong WW and Kufe DW. . 1997 J. Biol. Chem. 272: 1965–1969.
Datta R, Taneja N, Sukhatme VP, Qureshi SA, Weichselbaum R and Kufe DW. . 1993 Proc. Natl. Acad. Sci. USA 90: 2419–2422.
Green DR and Reed JC. . 1998 Science 281: 1309–1312.
Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Woshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW. . 1998 Cell 94: 339–352.
Hallahan DE, Dunphy E, Virudachalam S, Sukhatme VP, Kufe DW and Weichselbaum RR. . 1995 J. Biol. Chem. 270: 30303–30309.
Hu Y, Ding L, Spencer DM and Nunez G. . 1998 J. Biol. Chem. 273: 33489–33494.
Kataoka T, Schroter M, Hahne M, Schneider P, Irmler M, Thome M, Froelich CJ and Tschopp J. . 1998 J. Immunol. 161: 3936–3942.
Kerr JF, Wyllie AH and Currie AR. . 1972 Br. J. Cancer 26: 239–257.
Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R, Nalin C and Kufe D. . 1997 Proc. Natl. Acad. Sci. USA 94: 6939–6942.
Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC. . 1993 Cancer Res. 53: 4701–4714.
Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P and Flavell RA. . 1998 Cell 94: 325–337.
Lee SJ, Dimtchev A, Lavin MF, Dritschilo A and Jung M. . 1998 Oncogene 17: 1821–1826.
Li N and Karin M. . 1998 Proc. Natl. Acad. Sci. USA 95: 13012–13017.
Li PF, Dietz R and von Harsdorf R. . 1999 EMBO J. 18: 6027–6036.
Liu Z-G, Hsu H, Goeddel DV and Micheal K. . 1996 Cell 87: 565–576.
Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. . 1998 Cell 94: 481–490.
Majima HJ, Oberley TD, Furukawa K, Mattson MP, Yen HC, Szweda LI and St Clair DK. . 1998 J. Biol. Chem. 273: 8217–8224.
Newton K and Strasser A. . 2000 J. Exp. Med. 191: 195–200.
Nieminen AL, Saylor AK, Tesfai SA, Herman B and Lemasters JJ. . 1995 Biochem. J. 307: 99–106.
Pan G, O'Rourke K and Dixit VM. . 1998 J. Biol. Chem. 273: 5841–5845.
Perkins CL, Fang G, CN Kim and Bhalla KN. . 2000 Cancer Res. 60: 1645–1653.
Radford IR. . 1999 Int. J. Radiat. Biol. 75: 521–528.
Reap EA, Roof K, Borrero M, Booker J and Cohen PL. . 1997 Proc. Natl. Acad. Sci. USA 94: 5750–5751.
Rehemtulla A, Hamilton CA, Chinnaiyan AM and Dixit VM. . 1997 J. Biol. Chem. 272: 25783–25786.
Rehemtulla A, Hamilton CA, Taneja N, Fridman J, Juan TSC, Maybaum J and Chinnaiyan A. . 1999 Neoplasia 1: 63–70.
Santana P, Pena LA, Haimovitz-Friedman A, Martim S, Green D, Mclougin M, Cordon-Cardo C, Schuchman EH, Fuks Z and Kolesnick R. . 1996 Cell 86: 189–199.
Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M and Kroemer G. . 1996 J. Exp. Med. 184: 1331–1341.
Tewari M and Dixit VM. . 1995 J. Biol. Chem. 270: 3255–3260.
Thornberry NA and Lazebnik Y. . 1998 Science 281: 1312–1316.
Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB. . 1997 Cell 91: 627–637.
Vander Heiden MG, Chandel NS, Li XX, Schumacker PT, Colombini M and Thompson CB. . 2000 Proc. Natl. Acad. Sci. USA 97: 4666–4671.
Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollett O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D. . 1998 Immunity 9: 267–276.
Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV and Mak TW. . 1998 Science 279: 1954–1958.
Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TW. . 1998 Cell 94: 739–750.
Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM and Salvesen GS. . 1997 J. Biol. Chem. 272: 7797–7800.
Zou H, Li Y, Liu X and Wang X. . 1999 J. Biol. Chem. 274: 11549–11556.
Acknowledgements
We would like to acknowledge Amy Pace for help with preparation of figures. This work was partly supported by the UMCC (G00351 to N Taneja), the NIH (CA 78041 to A Rehemtulla) and the MDRTC, University of Michigan (ES 08846 to MA Philbert).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taneja, N., Tjalkens, R., Philbert, M. et al. Irradiation of mitochondria initiates apoptosis in a cell free system. Oncogene 20, 167–177 (2001). https://doi.org/10.1038/sj.onc.1204054
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204054
Keywords
This article is cited by
-
Evaluation of circulating cell-free nucleic acids in health workers occupationally exposed to ionizing radiation
Environmental Science and Pollution Research (2022)
-
Exploring subcellular responses of prostate cancer cells to X-ray exposure by Raman mapping
Scientific Reports (2019)
-
Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors
Cancer Gene Therapy (2007)
-
Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics
Oncogene (2002)
-
Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells
Oncogene (2002)